West Pharmaceutical Services Inc (WST) stock news · P/E 35, rev $1.72B
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
This WST news page leads with what West Pharmaceutical Services Inc filed — not a scraped headline mill.
No cached 8-K sentence for WST yet. We will not pad this page with generic market recap.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the WST stock page; for the tape open the quote page.
Not investment advice.